A balanced diet with controlled carbohydrate portions, distributed across three meals and two to three snacks daily, helps maintain stable glucose levels
Given the impact of type 2 diabetes on cardiovascular and neurological diseases, GLP-1 agonists and SGLT2 inhibitors represent a valid pharmacological tool for improving cardiometabolic profile and diabetes-related cognitive impairment
Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells
The * symbol indicates a significant difference between the control WT group and either untreated Pla2g6 / (WT vs Pla2g6 / ) or treated Pla2g6 / mice (WT vs Pla2g6 / Semaglutide)
50 : Over 90% of HCPs report high disease prevalence Patient adherence and lifestyle challenges remain the biggest barriers Strong shift toward advanced therapies like GLP-1 receptor agonists and SGLT2 inhibitors Only ~70% satisfaction with current patient outcomes Clear regional differences in therapy adoption and cost considerations These insights highlight the urgent need for patient-centric care, improved access to therapies, and multidisciplinary treatment approaches
Checking your benefits documentation or calling your insurer directly is the most reliable way to understand your coverage
